Sesti G, Antonelli Incalzi R, Bonora E, Consoli A, Giaccari A, Maggi S, et al. Management of diabetes in older adults. Nutr Metab Cardiovasc Dis [Internet]. 2018;28:206–18.
Freeman J. Management of hypoglycemia in older adults with type 2 diabetes. Postgrad Med. 2019;131:241–50.
Schernthaner G, Schernthaner-Reiter MH. Diabetes in the older patient: heterogeneity requires individualisation of therapeutic strategies. Diabetologia. 2018;61:1503–16.
PubMed PubMed Central Google Scholar
Mattishent K, Richardson K, Dhatariya K, Savva GM, Fox C, Loke YK. The effects of hypoglycaemia and dementia on cardiovascular events, falls and fractures and all-cause mortality in older individuals: a retrospective cohort study. Diabetes Obes Metab [Internet]. 2019;21:2076–85.
Mattishent K, Loke YK. Bi-directional interaction between hypoglycaemia and cognitive impairment in elderly patients treated with glucose-lowering agents: a systematic review and meta-analysis. Diabetes Obes Metab [Internet]. 2016;18:135–41. https://doi.org/10.1111/dom.12587.
Thompson AM, Linnebur SA, Vande Griend JP, Saseen JJ. Glycemic targets and medication limitations for type 2 diabetes mellitus in the older adult. Consult Pharm. 2014;29:110–23.
Abdelhafiz AH, Rodríguez-Mañas L, Morley JE, Sinclair AJ. Hypoglycemia in older people—a less well recognized risk factor for frailty. Aging Dis [Internet]. 2015;6:156–67.
Lin B, Coleman RL, Bragg F, Maddaloni E, Holman RR, Adler AI. Younger-onset compared with later-onset type 2 diabetes: an analysis of the UK Prospective Diabetes Study (UKPDS) with up to 30 years of follow-up (UKPDS 92). Lancet Diabetes Endocrinol [Internet]. 2024;12:904–14.
Christiaens A, Henrard S, Boland B, Sinclair AJ. Overtreatment of older people with type 2 diabetes—a high impact frequent occurrence in need of a new definition. Diabetic Medicine [Internet]. 2023;40: e14994.
Freeman J. Management of hypoglycemia in older adults with type 2 diabetes. Postgrad Med [Internet]. 2019;131:241–50.
Lipska KJ, Krumholz H, Soones T, Lee SJ. Polypharmacy in the aging patient: a review of glycemic control in older adults with type 2 diabetes. JAMA [Internet]. 2016;315:1034.
Nakhleh A, Shehadeh N. Hypoglycemia in diabetes: an update on pathophysiology, treatment, and prevention. World J Diabetes [Internet]. 2021;12:2036.
Desouza CV, Bolli GB, Fonseca V. Hypoglycemia, diabetes, and cardiovascular events. Diabetes Care [Internet]. 2010;33:1389.
Fanelli CG, Lucidi P, Bolli GB, Porcellati F. Hypoglycemia. Endocrinology (Switzerland) [Internet]. 2019. https://doi.org/10.1007/978-3-319-27316-7_22-2.
Rossetti P, Porcellati F, Bolli GB, Fanelli CG. Prevention of hypoglycemia while achieving good glycemic control in type 1 diabetes: the role of insulin analogs. Diabetes Care [Internet]. 2008;31(Suppl 2):S113–20.
Sherwin RS. Bringing light to the dark side of insulin: a journey across the blood-brain barrier. Diabetes [Internet]. 2008;57:2259.
Martín-Timón I, del Cañizo-Gómez FJ. Mechanisms of hypoglycemia unawareness and implications in diabetic patients. World J Diabetes [Internet]. 2015;6:912.
Bellary S, Barnett AH. SGLT2 inhibitors in older adults: overcoming the age barrier. Lancet Healthy Longev [Internet]. 2023;4:e127–8.
Nauck MA, Quast DR, Wefers J, Meier JJ. GLP-1 receptor agonists in the treatment of type 2 diabetes—state-of-the-art. Mol Metab [Internet]. 2020;46: 101102.
Ghosh S, Ghosh R. Glargine-300: An updated literature review on randomized controlled trials and real-world studies. World J Diabetes [Internet]. 2020;11:100.
Woo VC. A review of the clinical efficacy and safety of insulin degludec and glargine 300 U/mL in the treatment of diabetes mellitus. Clin Ther. 2017;39:S12-33.
Toschi E, Munshi MN. Benefits and challenges of diabetes technology use in older adults. Endocrinol Metab Clin North Am [Internet]. 2019;49:57.
Buse JB, Friedewald WT, Bigger JT, Byington RP, Cushman WC, Genuth S, et al. Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods. Am J Cardiol [Internet]. 2007;99:21i–33i.
Tran K, Reaven P. Review of the veteran affairs diabetes trial: Lessons learned. Rev Endocr Metab Disord [Internet]. 2020;21:537–46.
Moser O, Rafferty J, Eckstein ML, Aziz F, Bain SC, Bergenstal R, et al. Impact of severe hypoglycaemia requiring hospitalization on mortality in people with type 1 diabetes: a national retrospective observational cohort study. Diabetes Obes Metab [Internet]. 2023;25:2243–54.
Bolt J, Carvalho V, Lin K, Lee SJ, Inglis C. Systematic review of guideline recommendations for older and frail adults with type 2 diabetes mellitus. Age Ageing [Internet]. 2024. https://doi.org/10.1093/ageing/afae259.
Cersosimo E, Lee PG, Pandya N. Challenges of diabetes care in older people with type 2 diabetes and the role of basal insulin. Clin Diabetes [Internet]. 2019;37:357.
Lin YK, Fisher SJ, Pop-Busui R. Hypoglycemia unawareness and autonomic dysfunction in diabetes: lessons learned and roles of diabetes technologies. J Diabetes Investig [Internet]. 2020;11:1388–402. https://doi.org/10.1111/jdi.13290.
Betônico CCR, Titan SMO, Correa-Giannella MLC, Nery M, Queiroz M. Management of diabetes mellitus in individuals with chronic kidney disease: therapeutic perspectives and glycemic control. Clinics [Internet]. 2016;71:47.
Husain KH, Sarhan SF, AlKhalifa HKAA, Buhasan A, Moin ASM, Butler AE. Dementia in diabetes: the role of hypoglycemia. Int J Mol Sci [Internet]. 2023;24:9846.
Kandimalla R, Thirumala V, Reddy PH. Is Alzheimer’s disease a type 3 diabetes? A critical appraisal. Biochim Biophys Acta. 2017;1863:1078–89.
Abdelhafiz AH, Sinclair AJ. Cognitive frailty in older people with type 2 diabetes mellitus: the central role of hypoglycaemia and the need for prevention. Curr Diabetes Rep [Internet]. 2019;19:15.
Thaenpramun R, Komolsuradej N, Buathong N, Srikrajang S. Association between glycaemic control and malnutrition in older adults with type 2 diabetes mellitus: a cross-sectional study. Br J Nutr [Internet]. 2024;131:1497–505.
Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing [Internet]. 2019;48:16–31.
Deng Y, Sato N. Global frailty screening tools: review and application of frailty screening tools from 2001 to 2023. Intractable Rare Dis Res [Internet]. 2024;13:1.
Peron EP, Ogbonna KC, Donohoe KL. Diabetic medications and polypharmacy. Clin Geriatr Med [Internet]. 2014;31:17.
Jang HC. Sarcopenia, frailty, and diabetes in older adults. Diabetes Metab J [Internet]. 2016;40:182.
Heller SR. A summary of the ADVANCE Trial; 2009. http://diabetesjournals.org/care/article-pdf/32/suppl_2/S357/605900/zdc1110900s357.pdf [cited 2025 Apr 9].
Hölzen L, Schultes B, Meyhöfer SM, Meyhöfer S. Hypoglycemia unawareness—a review on pathophysiology and clinical implications. Biomedicines [Internet]. 2024;12:391.
Cryer PE, Davis SN, Shamoon H. Hypoglycemia in diabetes. Diabetes Care. 2003;26:1902–12.
Christou MA, Christou PA, Kyriakopoulos C, Christou GA, Tigas S. Effects of hypoglycemia on cardiovascular function in patients with diabetes. Int J Mol Sci [Internet]. 2023;24:9357.
Rasmussen NH, Dal J. Falls and fractures in diabetes-more than bone fragility. Curr Osteoporos Rep [Internet]. 2019;17:147–56.
Martins JM, Aranha P. Bone turnover and bone mineral density in old persons with type 2 diabetes. J Clin Transl Endocrinol [Internet]. 2018;14:12.
Nardone I, Antonelli R, Zaccaria S, WoldeSellasie S, Falcone S, Pecchioli C, et al. Prevalence of diabetes mellitus and clinical differences in patients with severe osteoporosis and fragility fractures. J Clin Med [Internet]. 2024;13:2670.
Lee AK, Juraschek SP, Windham BG, Lee CJ, Sharrett AR, Coresh J, et al. Severe hypoglycemia and risk of falls in type 2 diabetes: the atherosclerosis risk in communities (ARIC) study. Diabetes Care [Internet]. 2020;43:2060.
Snell-Bergeon JK, Wadwa RP. Hypoglycemia, diabetes, and cardiovascular disease. Diabetes Technol Ther [Internet]. 2012;14:S-51.
Comments (0)